Skip to main content
Dryad

90-day mortality in AKI-D and CKD5-D patients admitted to the ICU

Data files

Dec 16, 2025 version files 718.51 KB

Click names to download individual files

Abstract

Acute kidney injury (AKI) and chronic kidney disease (CKD) are related conditions commonly encountered in intensive care. While both may require renal replacement therapy (RRT), critically ill patients with dialysis-requiring AKI have significantly higher mortality and poor clinical outcomes than those with end-stage CKD. To compare 90-day mortality between patients with KDIGO stage 3 dialysis-requiring AKI (AKI-D) and those with stage 5 dialysis-dependent CKD (CKD5-D) admitted to the ICU. Secondary objectives were to identify independent predictors of increased 90-day mortality among AKI-D and CKD5-D patients, and to identify independent predictors of RRT at 90 days among patients who experienced an episode of AKI-D. This retrospective, single-center cohort study included adult patients with AKI-D or CKD5-D admitted to the ICU of a private quaternary hospital in São Paulo, Brazil. The study was approved by the Research Ethics Committee (CEP) of the Federal University of São Paulo, with a waiver of informed consent. The primary outcome was 90-day mortality. Multivariable logistic regression was used to identify independent predictors of mortality and dialysis dependence. A total of 2,377 patients were included: 1,878 (79%) with AKI-D and 499 (21%) with CKD5-D. The overall 90-day mortality was 42.5%, significantly higher in the AKI-D (50.3% vs. 13.2%; p <0.001) compared to CKD5-D group. Independent predictors of 90-day mortality among AKI-D and CKD5-D patients included older age, the need for vasoactive drugs, mechanical ventilation and diagnosis of sepsis. Among 731 AKI-D survivors assessed at 90 days, 175 (23.9%) remained dialysis-dependent. Risk factors for persistent dialysis dependence included older age, coronary artery disease, clinical (non-surgical) admission, and higher baseline creatinine. The risk of death in critically ill patients with AKI-D was more than three times higher than in individuals with CKD5-D. Although both AKI-D and CKD5-D patients experience loss of renal function, the factors correctable by dialysis alone do not account for the mortality difference between these groups. Rather, the severity of the acute illness, reflected by the need for invasive mechanical ventilation and vasoactive drugs, emerged as key determinants of short-term outcomes in this cohort.